Single-agent gemcitabine for biliary tract cancers. Study outcomes and systematic review of the literature.
暂无分享,去创建一个
E. Hatano | R. Doi | T. Nishimura | I. Ikai | S. Teramukai | M. Fukushima | T. Kiba | S. Matsumoto | T. Kitano | K. Yanagihara | Tsutomu Nishimura | A. Mori | H. Ishiguro | K. Yoshikawa | S. Yasumi | Emiko Doi